ArticleCancer medicine2019

A favorable inductive remission rate for decitabine combined with chemotherapy as a first course in <60-year-old acute myeloid leukemia patients with myelodysplasia syndrome features.

Fengqi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.